APVO - Aptevo Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $1195693.93. This is a potential upside of $1195684.27 (12377683.95%) from yesterday's end of day stock price of $9.66.

Aptevo Therapeutics's activity chart (see below) currently has 8 price targets and 23 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 23-Sep-2024. First documented stock forecast 05-Oct-2017.

Best performing analysts who are covering APVO - Aptevo Therapeutics:

Edward Tenthoff Jonathan Aschoff Wangzhi Li

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 09-Nov-2020

1 years 3 months 18 days ago
(23-Sep-2024)

0/2 (0%)

$777532.81 (91.42%)

Buy

Since 28-Feb-2020

3 years 4 months 29 days ago
(12-Aug-2022)

0/2 (0%)

$1725680 (331.25%)

Buy

Since 05-Nov-2018

$2083840

$2083830.38 (21571742.00%)

5 years 2 months 1 days ago
(09-Nov-2020)

0/1 (0%)

$1083840 (108.38%)

Show more analysts

Please expand the browser size to see the chart

What is APVO (Aptevo Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on APVO (Aptevo Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on APVO (Aptevo Therapeutics) with a proven track record?

WANGZHI LI

Which analyst has the most public recommendations on APVO (Aptevo Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on APVO

Which analyst is the currently most bullish on APVO (Aptevo Therapeutics)?

Wangzhi Li with highest potential upside - $2083830.38

Which analyst is the currently most reserved on APVO (Aptevo Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?